Filing Details
- Accession Number:
- 0001179110-19-002266
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 17:56:14
- Reporting Period:
- 2019-02-20
- Accepted Time:
- 2019-02-21 17:56:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1428336 | Healthequity Inc | HQY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1179972 | G Darcy Mott | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-20 | 4,000 | $77.87 | 74,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $14.00 | 2024-07-30 | 60,000 | 60,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $41.28 | 2027-03-27 | 19,897 | 19,897 | Direct | |
| Common Stock | Stock Option (right to buy) | $25.39 | 2025-03-26 | 25,000 | 25,000 | Direct | |
| Common Stock | Stock Option (right to buy) | $61.72 | 2028-03-27 | 14,228 | 14,228 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-07-30 | 60,000 | 60,000 | Direct |
| 2027-03-27 | 19,897 | 19,897 | Direct |
| 2025-03-26 | 25,000 | 25,000 | Direct |
| 2028-03-27 | 14,228 | 14,228 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.37 to $78.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
- The option is immediately exercisable.
- The option is exercisable as to 4,974 shares. The remaining shares become exercisable in two annual installments of 4,974 shares on March 27, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021.
- The option is exercisable as to 18,750 shares. The remaining shares become exercisable on March 26, 2019
- The option becomes exercisable in four equal installments of 3,557 shares on March 27, 2019, 2020, 2021, and 2022.
Billionaire Hedge Funds
